论文部分内容阅读
目的探讨克林霉素磷酸酯治疗呼吸系统感染患者的临床疗效。方法选取2014年1-6月河南省南阳市卧龙区第一人民医院收治的160例呼吸系统感染患者作为研究对象,按抽签方式将其分为对照组和试验组,各80例。对照组患者给予克林霉素进行治疗,试验组患者给予克林霉素磷酸酯,比较两组患者的临床疗效及不良反应发生情况。结果试验组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05);试验组患者的不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论克林霉素磷酸酯治疗呼吸系统感染类疾病临床治疗效果明显,还能降低各类不良反应的发生。
Objective To investigate the clinical efficacy of clindamycin phosphate in the treatment of respiratory infections. Methods One hundred and sixty patients with respiratory system infection admitted to the First People’s Hospital of Wolong District, Nanyang City, Henan Province from January to June 2014 were selected as the research objects. They were divided into control group and experimental group by lottery. Patients in the control group were treated with clindamycin. Patients in the test group were given clindamycin phosphate. The clinical efficacy and adverse reactions of the two groups were compared. Results The total effective rate of treatment in experimental group was significantly higher than that in control group (P <0.05). The incidence of adverse reactions in experimental group was significantly lower than that in control group (P <0.05) . Conclusion Clindamycin phosphate treatment of respiratory diseases have obvious clinical effects, but also reduce the incidence of various types of adverse reactions.